Ripple Price Analysis: XRP Remains Weak Against Both BTC and USD
Ripple’s native token has been under pressure over the past two weeks, giving up almost all of its strong Q3 gains. While Bitcoin’s dominance has surged, altcoins like XRP are struggling to hold critical support levels. However, the charts still show some structure holding for now.
Technical Analysis
By Shayan
The USDT Pair
On the USDT chart, XRP has pulled back from the upper boundary of its broad ascending channel and is now testing the lower trendline. The asset is currently positioned just below the 100-day and 200-day moving averages, with the latter serving as immediate resistance at around $2.60.
A break below the lower boundary of the channel could expose the $2 demand zone. With the RSI also hovering around 40, the momentum is bearish but not oversold, suggesting more room for downside if support fails.
The BTC Pair
Looking at the BTC pair, the situation appears weaker. XRP has broken below the long-standing support around 2,500 SAT and is struggling to reclaim the 200-day MA. After a sharp drop to the 2,000 area, the price has found temporary stability but still trades below key resistance levels.
The RSI also remains stuck near 39, showing that relative strength is lacking compared to Bitcoin. Therefore, the buyers need to reclaim the 2,500 zone soon to regain momentum. Otherwise, XRP is likely to continue its decline against BTC.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.
STONK hits new highs after erasing 27% crash
25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
Crypto prices
More
